1. Brunning, R.D., Bennett, J.M., Flandrin, G., Matutes, E., Head, D., Vardiman, J.W., and Harris, N.L. (2001) Myelodysplastic syndromes. In: World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues (Eds. Jaffe, E.S., Harris, N.L., Stein, H., and Vardiman, J.W.), pp 61–73, IARC Press: Lyon.
2. Brunning, R.D., Orazi, A., Germing, U., Le Beau, M.M., Porwit, A., Bauman, I., Vardiman, J.W., and Hellstrom-Lindberg, E. (2008) Myelodysplastic syndromes. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Eds. Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J., and Vardiman, J.W.), pp 87–107, IARC Press: Lyon.
3. Olney, H.J. and Le Beau, M.M. (2007) Evaluation of recurring cytogenetic abnormalities in the treatment of myelodysplastic syndromes. Leuk Res 31,427–34.
4. Haase, D. (2008) Cytogenetic features in myelodysplastic syndromes. Ann Hematol 87, 515–26.
5. Bernasconi, P., Boni, M., Cavigliano, P.M., Calatroni, S., Giardini, I., Rocca, B., Zappatore, R., Dambruoso, I., and Caresana, M. (2006) Clinical relevance of cytogenetics in myelodysplastic syndromes. Ann NY Acad Sci 1089, 395–410.